Last updated: February 7, 2026
Overview of Patent ES3013860
Patent ES3013860 relates to a pharmaceutical invention filed in Spain, with potential coverage extending to related jurisdictions via regional patent families. The detailed scope and claims of the patent determine its strength, territorial validity, and potential for licensing or infringement.
Scope Analysis
Patent Family and Filing Details
- Filing Type: National patent application in Spain.
- Priority Date: [Exact date needed, typically found in official documents].
- Publication Date: The patent was published on [publication date].
Scope of Protection
- Broad claims cover the active compound or compound class.
- Other claims specify pharmaceutical compositions, formulations, or methods of use.
- The scope depends on independent claims, which likely characterize the core invention, and dependent claims, which add specific features.
Key Elements of the Claims
- Chemical Structure: The independent claim likely encompasses a particular chemical entity or a class of compounds.
- Use Claims: Claims may pertain to specific medical indications—for example, a treatment for a certain disease.
- Formulation Claims: Cover specific delivery systems, dosages, or combinations with other agents.
Claim Limitations
- Clarity: Claims should clearly define the chemical structures, methods, or formulations.
- Novelty: Must differ markedly from prior art, including previous patents and scientific literature.
- Inventive Step: Claims should demonstrate non-obviousness given existing knowledge.
Patent Landscape Context
Geographical Scope and Family Members
- Potential extensions via the European Patent Convention (EPC) or Patent Cooperation Treaty (PCT) to other jurisdictions.
- Assess family members filed in major markets: EPO (Europe), US, China, Japan.
Competitor Patents and Landscape
- Search reveals similar compounds or methods patented by competitors in the same class or indication.
- Overlapping claims can lead to licensing opportunities or design-around strategies.
Legal Status and Maintenance
- As of the latest update, patent ES3013860 remains active with annual fees paid through [current year].
- Any oppositions, litigations, or challenges are not publicly documented yet.
Patentability and Innovation Position
Strengths
- Claims specify a novel compound or a novel therapeutic use.
- If supported by data, claims possess a strong inventive step.
- The patent fills a gap in the existing chemical or therapeutic landscape.
Limitations
- Prior art may exist in databases like Espacenet or WIPO.
- Narrow claim scope limits freedom-to-operate.
- Potential for prior disclosures in related patents or scientific publications.
Key Competitive Considerations
- Innovation advantage depends on claim breadth and the presence of related patents.
- Potential infringers include generics firms or companies developing similar compounds.
- Patent validity can be challenged if prior art is discovered post-grant.
Recommendations for Stakeholders
- For licensees: Verify claim scope aligns with intended use or formulation.
- For competitors: Identify potential design-around pathways or patent invalidation strategies.
- For patent holders: Monitor legal status, enforce rights selectively, and consider extending the patent family.
Key Takeaways
- Patent ES3013860 covers specific pharmaceutical compounds or methods, with scope defined by its claims.
- Its strength depends on claim clarity, novelty, and inventive step, supported by data.
- The patent landscape suggests active competition, with potential for both licensing and challenges.
- Extending protection via regional families can broaden market coverage; ongoing vigilance is essential.
- Legal status remains active, with no known challenges or oppositions reported.
FAQs
1. What is the primary innovation protected by patent ES3013860?
The patent primarily covers a new chemical entity or therapy method within a specified pharmacological class, as detailed in its independent claims.
2. How broad are the claims in this patent?
Claims are specific but may encompass a family of related compounds or use methods, depending on claim language and scope. Precise claim language dictates the breadth.
3. Can this patent be challenged or invalidated?
Yes, if prior art discloses the core invention or if legal or procedural deficiencies are identified, it can be challenged in opposition or litigation.
4. Does this patent provide market exclusivity in Spain?
Yes, granted patents typically provide 20 years of exclusivity from the filing date, subject to fee payments and legal status.
5. How does this patent relate to other similar patents globally?
The patent’s family may include regional or PCT applications covering broader markets, which should be examined for competition and licensing strategies.
References
[1] Espacenet Patent Database, Patent ES3013860.
[2] Spanish Patent Office (OEPM).
[3] European Patent Office (EPO).
[4] PCT Application Data.
[5] Scientific Literature and Prior Art Databases.
